Home - Products - Others - Other Targets - Saponin C, from Liriope muscari

Saponin C, from Liriope muscari

CAS No. 130551-41-6

Saponin C, from Liriope muscari ( —— )

Catalog No. M31381 CAS No. 130551-41-6

Saponin C from Liriope muscari can be extracted from Liriope muscari, family Liliaceae.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 83 In Stock
10MG 119 In Stock
25MG 188 In Stock
50MG 276 In Stock
100MG 421 In Stock
200MG 620 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Saponin C, from Liriope muscari
  • Note
    Research use only, not for human use.
  • Brief Description
    Saponin C from Liriope muscari can be extracted from Liriope muscari, family Liliaceae.
  • Description
    Saponin C from Liriope muscari can be extracted from Liriope muscari, family Liliaceae.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    130551-41-6
  • Formula Weight
    871
  • Molecular Formula
    C44H70O17
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (114.81 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Dextrothyroxine

    Dextrothyroxine could lower cholesterol and also increases hepatic lipase which in turn improves utilization of triglycerides, leading to improve apolipoprotein E cholesterol particles.

  • Glychionide A

    Glychionide A is a natural product.

  • Nogo-66 (1-40)

    Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.